CoChat

Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials

Fogacci, Federica, Tocci, Giuliano, Presta, Vivianne, Fratter, Andrea, Borghi, Claudio, Cicero, Arrigo F. G. · 2019 · Critical Reviews in Food Science and Nutrition
Cited by 141

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Introduction: Results of previous clinical trials evaluating the effect of resveratrol supplementation on blood pressure (BP) are controversial.Purpose: We aimed to assess the impact of resveratrol on BP through systematic review of literature and meta-analysis of available randomized, controlled clinical trials (RCTs).Methods: Literature search included SCOPUS, PubMed-Medline, ISI Web of Science and Google Scholar databases up to 17th October 2017 to identify RCTs investigating the impact of resveratrol on BP. Two review authors independently extracted data on study characteristics, methods and outcomes. Overall, the impact of resveratrol on BP was reported in 17 trials.Results: Administration of resveratrol did not significantly affect neither systolic BP [weighted mean difference (WMD): −2.5 95% CI:(-5.5, 0.6) mmHg; p=0.116; I2=62.1%], nor diastolic BP [WMD: −0.5 95% CI:(-2.2, 1.3) mmHg; p=0.613; I2=50.8], nor mean BP [MAP; WMD: −1.3 95% CI:(-2.8, 0.1) mmHg; p=0.070; I2=39.5%] nor pulse pressure [PP; WMD: −0.9 95% CI:(-3.1, 1.4) mmHg; p=0.449; I2=19.2%]. However, significant WMDs were detected in subsets of studies categorized according to high resveratrol daily dosage (≥300 mg/day) and presence of diabetes. Meta-regression analysis revealed a positive association between systolic BP-lowering resveratrol activity (slope: 1.99; 95% CI: 0.05, 3.93; two-tailed p= 0.04) and Body Mass Index (BMI) at baseline, while no association was detected neither between baseline BMI and MAP-lowering resveratrol activity (slope: 1.35; 95% CI: −0.22, 2.91; two-tailed p= 0.09) nor between baseline BMI and PP-lowering resveratrol activity (slope: 1.03; 95% CI: −1.33, 3.39; two-tailed p= 0.39). Resveratrol was fairly well-tolerated and no serious adverse events occurred among most of the eligible trials.Conclusion: The favourable effect of resveratrol emerging from the current meta-analysis suggests the possible use of this nutraceutical as active compound in order to promote cardiovascular health, mostly when used in high daily dose (≥300 mg/day) and in diabetic patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/10408398.2017.1422480

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 30

  1. 10.1007/s40292-017-0236-x · DOI
  2. 10.1016/j.jconrel.2011.09.083 · DOI · Paper page
  3. Borenstein M., 2005, Biostatistics, 2005, 104
  4. 10.1111/bcp.12902 · DOI · Paper page
  5. 10.1016/j.phrs.2017.08.015 · DOI
  6. 10.1016/j.cgh.2014.02.024 · DOI · Paper page
  7. 10.1039/C7FO00178A · DOI · Paper page
  8. 10.1007/s40292-015-0081-8 · DOI
  9. 10.1111/j.0006-341X.2000.00455.x · DOI · Paper page
  10. Fogacci F., 2017, Critical Reviews in Food Science and Nutrition, 30, 0
  11. 10.1016/0895-4356(92)90054-Q · DOI · Paper page
  12. Higgins J., 2010, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0. 2. 2009
  13. 10.1536/ihj.16-373 · DOI · Paper page
  14. 10.7897/2230-8407.04849 · DOI
  15. 10.1210/jc.2016-2160 · DOI · Paper page
  16. 10.1016/j.niox.2011.12.006 · DOI · Paper page
  17. 10.1016/j.clnu.2014.03.009 · DOI · Paper page
  18. 10.1136/bmj.b2535 · DOI · Paper page
  19. 10.1155/2013/851267 · DOI · Paper page
  20. 10.1210/jc.2014-2799 · DOI · Paper page
  21. 10.1007/s11906-017-0785-3 · DOI
  22. 10.1016/j.metabol.2016.08.007 · DOI
  23. 10.1016/j.ijcard.2015.04.008 · DOI · Paper page
  24. 10.3892/etm.2015.2895 · DOI · Paper page
  25. 10.3109/07853890.2015.1078905 · DOI
  26. 10.21037/cdt.2017.03.20 · DOI · Paper page
  27. 10.1007/s10557-012-6427-8 · DOI · Paper page
  28. 10.2337/dc16-0499 · DOI · Paper page
  29. 10.1124/dmd.104.000885 · DOI · Paper page
  30. 10.1016/j.cmet.2012.09.015 · DOI · Paper page

Cited by

See all 141

Metadata

Authors
Fogacci, F., Tocci, G., Presta, V., Fratter, A., Borghi, C., & Cicero, A. F. G.
Venue
Critical Reviews in Food Science and Nutrition
Published
2018-01-23
Volume
59
Issue
10
Pages
1605-1618
ISSN
  • 1040-8398 (ISSN-L)
  • 1549-7852
OpenAlex
W2791625216
Cited by
141
References
16
FWCI
1.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. https://app.cochat.ai/papers/10.1080/10408398.2017.1422480
The paper
Fogacci, F., Tocci, G., Presta, V., Fratter, A., Borghi, C., & Cicero, A. F. G. (2019). Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2017.1422480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.